Skip to main content

Table 1 Dendritic cell yield in patients with cancer and healthy donors

From: Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

DC source DC yield (%)
Healthy donors (n = 8) 12.5 ± 5.0
Patients with colorectal cancer (n = 4) 5.9 ± 2.6
Patients with breast cancer (n = 6) 3.1 ± 1.2*
  1. Peripheric blood mononuclear cells (PBMCs) were cultured with granulocyte–macrophage colony-stimulating factor and IL-4. Data presented are the dendritic cell (DC) yield after 7 days: number of CD11c+Lin- cells/number of PBMCs at day 0. DCs were prepared from blood of healthy donors, patients with colorectal cancer, or patients with breast cancer. *P < 0.01 versus donors.